BRAF mutations in Papillary Thyroid Cancer have shown to be associated with aggressiveness and adverse outcomes. This endocrine malignancy has recently become very common, and found more in women. Her study focuses on BRAF V600E mutation, in Kerala population and the various signalling pathways implicated.